DGAP-News: Epigenomics AG / Key word(s): Conference
2016-11-14 / 17:48
Epigenomics AG to participate in investor conferences
Berlin (Germany) and Germantown, MD (U.S.A.), November 14, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) today announced that Greg Hamilton, Chief Executive Officer, will participate in the following investor conferences:
– Canaccord Genuity Medical Technologies & Diagnostics Forum, Thursday November 17, 2016, New York, Westin New York Grand Central, Presentation: 10:00 am (EST)
– German Equity Forum 2016, Tuesday, November 22, 2016, Frankfurt, Sheraton Frankfurt Airport Hotel, Presentation: 5:00 PM (CET)
– goetzpartners Interdisciplinary Oncology Insight Symposium, November 29, 2016, London, Le Meridien Piccadilly, Panel discussion: 2:00 PM (GMT)
For more information, visit www.epigenomics.com.
Contact Epigenomics AG
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||+49 30 24345-0|
|Fax:||+49 30 24345-555|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|